Initiation of Prenatal Diagnosis Test for Thalassemia/Sickle Cell Carrier Status in Pregnant Women in-house in collaboration with Fernandez Hospital

Initiation of Prenatal Diagnosis Test for Thalassemia/Sickle Cell Carrier Status in Pregnant Women
Kamala Hospital and Research Centre, a unit of the Thalassemia & Sickle Cell Society (TSCS), Hyderabad, has taken a significant step toward the prevention of genetic blood disorders by initiating Prenatal Diagnosis (PND) testing for couples identified as Thalassemia or Sickle Cell carriers. This initiative is an essential component of the society’s comprehensive prevention program aimed at reducing the birth of children affected with Thalassemia Major and Sickle Cell Anemia.

Through its ongoing antenatal screening program, TSCS identifies carrier couples early in pregnancy. When both partners are found to be carriers, the unborn child has a 25% chance of being affected in each pregnancy. In such cases, TSCS offers prenatal diagnostic testing during the first trimester, in collaboration with Fernandez Foundation, Hyderabad.

This initiative not only empowers families with crucial genetic health information but also reinforces TSCS’s mission to prevent new cases of Thalassemia and Sickle Cell Anemia through early detection and timely intervention, ultimately contributing to a Thalassemia/Sickle Cell Anemia-free future.
TSCS is the only NGO in India to offer this facility for the prevention of both Thalassemia and Sickle Cell Anemia.